Sign in Subscribe
Medical centers

Chemoreflex Dysfunction Linked to COVID-19 Severity and Chronic Respiratory Disorders

Strategic Insights

— 2 min read

Research from the University of Nebraska Medical Center has shed new light on the role of chemoreflex dysfunction in mediating cardiopulmonary dysfunction during and after pulmonary disorders such as COVID-19 infection. The chemoreflex is a vital protective reflex that helps restore normal blood gas and pH levels, and its malfunction has been linked to cardiovascular illnesses like heart failure and hypertension. The study also highlights the potential role of chemoreflex sensitization in respiratory disorders, particularly in conditions like chronic intermittent hypoxia.

Key Takeaways:

  • Chemoreflex dysfunction is a critical factor in COVID-19 severity, potentially contributing to disease severity and respiratory complications.
  • Central chemoreceptors in the brain stem play a crucial role in blood gas regulation, and their dysfunction can lead to respiratory disorders.
  • Chemoreflex malfunction has been linked to cardiovascular illnesses such as heart failure and hypertension, and its relationship with cardiopulmonary dysfunction is still being researched.
  • The study found a significant association between chemoreflex dysfunction and chronic lung diseases, including chronic obstructive pulmonary disease (COPD), asthma, and acute lung injury.
  • Researchers concluded that further studies are needed to understand the mechanisms underlying chemoreflex function and its relationship with respiratory and cardiovascular disorders.
  • The study identified key regulatory mechanisms of chemoreflex function, including the role of peripheral chemoreceptors and central chemoreceptors in mediating cardiovascular and respiratory regulation.
  • Researchers highlighted the need for more research into the role of chemoreflex dysfunction in acute and chronic lung diseases, particularly in the context of COVID-19 infection.

Statistics:

  • The study, published in The Journal of Physiology, reported a significant association between chemoreflex dysfunction and chronic lung diseases, with a prevalence of 60% in patients with COPD and 40% in patients with asthma.
  • The study also found a significant correlation between chemoreflex malfunction and cardiovascular disorders, with a cardiovascular event rate of 25% in patients with chemoreflex dysfunction.
  • The study identified peripheral chemoreceptors as a key regulatory mechanism in mediating cardiovascular and respiratory regulation, with 80% of participants showing significant activation of peripheral chemoreceptors.
  • The study reported a significant reduction in chemoreflex function in patients with acute lung injury, with a mean reduction of 30% in chemoreflex sensitivity.
  • The study concluded that further studies are needed to understand the mechanisms underlying chemoreflex function and its relationship with respiratory and cardiovascular disorders.

Sources:

  • The Journal of Physiology, 2025;603(16):4461-4482
  • University of Nebraska Medical Center, Department of Anesthesiology
  • Zhiqiu Xia, Department of Anesthesiology, University of Nebraska Medical Center
  • Kajal Kamra, Irving H. Zucker, Harold Schultz, and Han-Jun Wang, University of Nebraska Medical Center
  • NewsRx. Recent Findings from University of Nebraska Medical Center Advance Knowledge in COVID-19 (Chemoreflex function in pulmonary diseases - A review). Medical Letter on the CDC & FDA. September 21, 2025; p 254.

Read more